Preferred Label : sotatercept;
MeSH note : a dimeric fusion protein consisting of the extracellular domain of the human ActRIIA
linked to the Fc portion of human IgG1 and may be an effective therapy in a variety
of diseases involving bone loss;
CISMeF synonym : ACE-011;
Is substance : O;
UNII : 0QI90BTJ37;
Origin ID : C542017;
UMLS CUI : C2703199;
Currated CISMeF NLP mapping
- MeSH indexing information
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3508311/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug therapy, combination
sotatercept
sotatercept
evaluation of the transparency committee
Pulmonary Arterial Hypertension
---
https://ansm.sante.fr/tableau-acces-derogatoire/sotatercept
2025
false
false
false
France
French
recombinant fusion proteins
Pulmonary Arterial Hypertension
guidelines for drug use
Pulmonary arterial hypertension WHO functional class III
Pulmonary arterial hypertension WHO functional class II
insurance, health, reimbursement
adult
sotatercept
summary of product characteristics
package leaflet
Pulmonary arterial hypertension WHO functional class IV
sotatercept
---
https://www.has-sante.fr/jcms/p_3658407/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire-htap
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
sotatercept
sotatercept
recombinant fusion proteins
drug therapy, combination
Pulmonary arterial hypertension WHO functional class IV
evaluation of the transparency committee
Pulmonary Arterial Hypertension
---
https://www.ema.europa.eu/en/medicines/human/EPAR/winrevair
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
orphan drug production
sotatercept
hypertension, pulmonary
injections, subcutaneous
drug approval
europe
adult
drug therapy, combination
activins
risk management
pregnancy
breast feeding
aged
drug evaluation, preclinical
sotatercept
sotatercept
---
https://www.has-sante.fr/jcms/p_3606289/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire-htap
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
drug therapy, combination
respiratory system agents
sotatercept
Pulmonary arterial hypertension WHO functional class II
Pulmonary arterial hypertension WHO functional class III
injections, subcutaneous
sotatercept
evaluation of the transparency committee
Pulmonary Arterial Hypertension
---
https://www.has-sante.fr/jcms/p_3508311/fr/sotatercept-sotatercept-hypertension-arterielle-pulmonaire
2024
false
false
false
France
sotatercept
adult
drug therapy, combination
Pulmonary arterial hypertension WHO functional class II
Pulmonary arterial hypertension WHO functional class III
guidelines for drug use
orphan drug production
sotatercept
evaluation of the transparency committee
Pulmonary Arterial Hypertension
---
